Dingdang Health Technology Group Ltd. (09886) released a Next Day Disclosure Return dated 28 November 2025, indicating no change to the total number of issued shares, which remains at 1,319,472,897. According to the announcement, a series of share repurchases were executed between 25 November 2025 and 28 November 2025, amounting to a total of 900,000 shares repurchased for cancellation but not yet canceled as of the closing balance date.

The disclosure shows 410,000 shares repurchased on 25 November 2025, followed by 170,000 on 26 November 2025, 69,000 on 27 November 2025, and 251,000 on 28 November 2025. The repurchase on 28 November 2025 involved an on-exchange transaction for 251,000 shares at a highest price of HKD1.09 and a lowest price of HKD1.08, resulting in an aggregate price of HKD273,288.8.

The repurchase mandate, approved on 28 May 2025, covers up to 131,947,289 shares; 900,000 shares have now been repurchased under this authorization, representing approximately 0.068209% of the issued shares at the time of the mandate’s approval. The announcement states that no new shares may be issued until 28 December 2025 without the prior approval of the Hong Kong Stock Exchange.